With international standardization of location of meridian points which are fundamental to acupuncture as a goal we studied the location of meridian points on the Yang meridians of the crus. The method of research was to adopt the descriptions of point locations round in the classics using the classics chronologically and adding to this information based on actual measurement, conduct our studies. As a standard local scale for Yang meridians on the crus, as in the KOTSUDO chapter the distance from the height of the knee split point to the lateral malleolus is 16 fcun and the distance from the fold line in the popliteal fossa (B40) to the superior border of the calcaneus is given as 16 fcun, point locations which could not be explained anatomically were proportionally distributed with in the local scale. Thus on the Stomach Meridian as the classic locations of S36 and S41 can be assumed and expressed anatomically and the other points lie between S35 and S41, S37 was determined 2/5 from S35, S38 and S40 in the middle and S39 2/5 from S41. On the Gall Bladder Meridian, G34 and G40 are determined anatomically and the other points between the knee split point and the lateral malleolus, G35 and G36 in the middle front or back, G37 1/3 from the lateral malleolus, G38 1/4 from the lateral malleolus and G39 1/5 from the lateral malleolus. On the Bladder Meridian between B40 and the superior border of the calcaneum protrubence, B55 is 1/8 from B40, B56 is 1/3 from B40, B57 and B58 midway medially or laterally and B59 1/5 from the calcaneum protrubence.

Objective: In this study, we conducted a questionnaire survey of hospital pharmacists throughout Japan with the aim of identifying the most-requested in-hospital preparations and off-label use drugs, and exploring the possibility of commercializing them.Methods: The Commercialization Study Group of the Japanese Society of Hospital Pharmacists conducted a questionnaire survey on the Japanese Society of Hospital Pharmacists website targeting hospital pharmacists who are members of the Japanese Society of Hospital Pharmacists. The period of the survey was from February 1, 2019 until January 21, 2020. In the questionnaire, the respondents wrote specific product names (generic names), specifications, and dosage forms that they would like to see improved and made commercially available in a free-text format. In addition, respondents chose their reasons for wanting the product to be improved or made commercially available from a list.Results: A total of 1,627 drugs were requested to be made commercially available. After duplicates and insufficient descriptions were excluded, the total was 553. The drugs that were most frequently requested were Levothyroxine suppositories, followed by Mohs’ ointment and Ulinastatin vaginal suppositories.Discussion: This survey identified certain drugs that pharmacists want to be commercialized and the specific reasons why. In-hospital preparations not only benefit patients whose diseases are becoming more complex and difficult to treat with existing prescription drugs, but also enable pharmacists to demonstrate their abilities. We believe that the commercialization of these important in-hospital preparations and off-label drugs will help avoid various risks associated with dispensing them and enhance the pharmacy profession. For this reason, pharmaceutical drug companies should conduct further surveys on the actual use of and literature research on the efficacy and safety of the drugs that were ranked high on the questionnaire and start considering their commercialization.